The Evolving Role of Sites in Virtual & Decentralized Trials: Interview with Mary Costello of Medable

by Molly Bryant Jan 20 , 2021 3 min read

Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how clinical research site management is changing – and marching towards sites being capable with decentralized clinical trials – in the face of the pandemic.

Mary’s more than 20 years of diverse experience in the industry position her well to provide insight from a variety of perspectives, including management, marketing, and the coordinator’s role.

She shares the new cornerstones of success that have emerged in the face of COVID, and illuminates ways we can all work together to help research sites deliver.

Enjoy this interview by video below, or by subscribing to our podcast on Simplecast, Spotify, or iTunes.

Mary Costello

Mary Costello is the Head of Site and Investigator Network at Medable. In her role she works to ensure that the site’s perspective helps to inform development.

Prior to joining Medable, Mary worked in software, clinical research, and marketing at diverse organizations, including Covance, Thermo Fisher Scientific, and eClinical Solutions.

She brings to the table a strong appreciation for the value of the stakeholders’ experience, and is pleased to be working with a female founder for the first time in her career.

Episode Highlights

  • How excellence in site management has changed since the pandemic.
  • Why the sites are still the lynchpin.
  • Why anxiety around decentralized clinical trials is misplaced.
  • How a marketing perspective can serve clinical operations and site management.
  • What sets sites apart that will succeed and sites that will struggle in this new landscape.
  • Why it’s important to assess a site’s tech-readiness and physical situation before handing down directions on how a study will be run.
  • Simply providing a site with technology isn’t enough, so what else needs to be done?
  • Why prevention and preparation beat correction and remediation.
  • How to maximize collected data through follow-up and implementation.

Resources:

Medable
Mary Costello on LinkedIn
Conversations in Clinical Trial Readiness Interview Series

Related Post

3 min Read 20 Apr, 2021

An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec

Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…

13 min Read 30 Mar, 2021

Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges

There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that…

Molly Bryant
Molly Bryant
14 min Read 24 Mar, 2021

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

The decentralized clinical trial is one of the most talked-about emerging trends in the life…

Molly Bryant
Molly Bryant